In joint disease, the inflammatory mediators present (IL-1β and TNF-α) will stimulate the hepatocytes to shift the cellular gene expression towards the production of APPs at the expense of albumin synthesis (systemic acute-phase reaction), resulting in an increase in serum and synovial concentrations of APPs (May, Hooke & Lees 1992). This evidence concerns the gene CTSB and arthropathy.